Quest Diagnostics (DGX) Tops Q1 Earnings, Raises '17 View
Zacks Investment Research | Apr 19, 2017 10:18PM ET
Quest Diagnostics’ (NYSE:DGX) first-quarter 2017 adjusted earnings per share (EPS) of $1.33 came in 13.7% ahead of the Zacks Consensus Estimate and exceeded the year-ago number by 17.7%.
Adjusted EPS in the reported quarter excludes charges related to restructuring and integration, retirement of debtas well as amortization expenses. Reported EPS in the first quarter came in at $1.16, representing a year-over-year surge of 63.4%.
Reported revenues for the first quarter inched up 1.9% year over year to $1.89 billion, ahead the Zacks Consensus Estimate of $1.87 billion. According to the company, the year-over-year improvement came on the back of expanding relationships with hospital health systems and strength in several of the company’s advanced diagnostic offerings.
Volume (measured by the number of requisitions) increased 3.5% year over year during the first quarter. Revenue per requisition, however, was down 0.2%. Diagnostic information services revenues in the quarter grew 3.2% on a year-over-year basis to $1.81 billion.
Quest Diagnostics Incorporated Price, Consensus and EPS Surprise
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.